|
Chronic Pain Modulation of Mesolimbic Dopamine Signaling for Natural and Opiate Rewards |
1F31DA056200-01 |
|
NIDA |
2022 |
|
Role of disability and pain in opioid overdose: mechanism and risk mitigation |
1R01DA053243-01A1 |
|
NIDA |
2022 |
|
A pilot study of ambulatory Heart Rate Variability Biofeedback for substance use disorder |
1R21DA056468-01 |
|
NIDA |
2022 |
|
Wearable sensor for opioids detection based on electrochemical sensor arrayintegrated with Bluetooth device |
2R44DA051289-02 |
|
NIDA |
2022 |
|
Systems biology of RNA Modifications in HIV/AIDS and Substance Use Disorders |
3R01DA046170-05S1 |
|
NIDA |
2022 |
|
Alzheimer’s disease and chronic pain |
3R21DA053824-02S1 |
|
NIDA |
2022 |
|
Using Augmented Reality illusion therapy to develop a non-opioid chronic pain digital treatment |
3R43DA053048-01S1 |
|
NIDA |
2022 |
|
Opioid-Sparing pain management for Chronic Low Back Pain patients using TMC-CP01 - A VANISH (Virtual Autonomic Neuromodulation Induced Systemic Healing) based program |
4R44DA049630-02 |
|
NIDA |
2022 |
|
Adhesion GPCR Cirl as a novel regulator of dopamine neurotransmission |
5F31DA053811-02 |
|
NIDA |
2022 |
|
Reversal of Opioid-Induced Pathological Neuroplasticity Through Timed Electrical Stimulation |
5R21DA052568-02 |
|
NIDA |
2022 |